Reliv Supplements and OCD: Not a Treatment—Seek Evidence-Based Care

Reliv products are dietary supplements (vitamins, minerals, protein, botanicals). They are not FDA-approved to treat, cure, or prevent any disease, including obsessive-compulsive disorder (OCD).

Evidence-Based OCD Treatment

• First-line psychotherapy: Cognitive-behavioural therapy with exposure and response prevention (CBT-ERP).
• First-line pharmacotherapy: SSRIs (fluoxetine, sertraline, fluvoxamine, paroxetine, escitalopram) at higher-than-depression doses for 8–12 weeks minimum.
• Augmentation: Atypical antipsychotics (risperidone, aripiprazole) for partial responders.
• Neuromodulation: TMS (FDA-cleared for OCD), deep brain stimulation (refractory).

Supplements in Psychiatry

• Some nutrients (NAC, glycine, inositol, omega-3) show preliminary adjunctive data but are not monotherapy alternatives.
• Supplements lack standardization, purity oversight, and rigorous RCT evidence for OCD.
• Potential interactions (e.g., St. John's wort with SSRIs → serotonin syndrome).

Action Steps

1. Consult a psychiatrist or psychologist specializing in OCD.
2. Obtain formal diagnosis (Y-BOCS assessment).
3. Initiate CBT-ERP and/or SSRI per guidelines.
4. Inform all providers about any supplements taken.

OCD is a treatable neurobiological condition. Delaying evidence-based care for unproven supplements risks symptom worsening and functional impairment.